beta-D-gentiobiosa, mínimo 98 %, para bioquímica, 500 mg, envase de vidrio

7-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indole-6-carbonitrile, 97%, 50mg

6-Bromo-1-hexene>95.0%(GC)5g

(3R,7AR)-3-PHENYLTETRAHYDROPYRROLO[1,2-C]OXAZOL-5(3H)-ONE, 95.0%, 1g

(R)-MESITYL PHENYL SULFOXIDE, 97.0%, 1g

tert-Butyl 3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 98%, 1g

2-Bromocumene>97.0%(GC)25g

(S)-3-Methylmorpholine hydrochloride, 95.0%, 5g

Ethyl 5-bromo-2-chlorothiazole-4-carboxylate, 95.0%, 100mg

(2-Amino-3-bromophenyl)methanol, 95.0%, 250mg

Ethyl 2-chloronicotinate, 95.0%, 100g

Z-Asp(OBzl)-OH, 98%, 100g

2-(2,3,4-Trifluorophenyl)pyridine>97.0%(GC)(T)1g